Shingrix was originally approved by the FDA in 2017 for the prevention of shingles in adults 50 years and older. Now, it’s approved for those 18 years and older who are immunocompromised.
Armand Butera
Advertisement
Articles by Armand Butera
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Infection Control Today
1
New US Ebola Travel Restrictions: What Infection Preventionists Need to Know About the 21-Day Return Policy
2
Can We Prepare for the Next Pandemic Without Studying Dangerous Pathogens? Experts Question New Gain-of-Function Policy
3
Cyclospora First Deaths: Expert Explains Why Cases Are So Difficult to Trace and What Infection Preventionists Should Know
4
Back-to-School Infection Prevention: Evidence-Based Strategies to Keep K–12 Students Healthy
5